Paper203386
Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
Weeks CE and 4 others. Cancer Res, 1978. Cited by 96 papers, by iCite.
Cite this record
ConductScience Library. Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium. Papers, record 203386. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/203386
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Role of arylhydroxamic acid acyltransferase in the mutagenicity of N-hydroxy-N-2-fluorenylacetamide in Salmonella typhimurium.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acyltransferases | Major topic |
| Fluorenes | Major topic |
| Hydroxyacetylaminofluorene | Major topic |
| Mutation | Major topic |
| Salmonella typhimurium | Major topic |
| Acetyltransferases | |
| Animals | |
| Drug Evaluation, Preclinical | |
| Guanosine Monophosphate | |
| Hydroxamic Acids | |
| In Vitro Techniques | |
| Liver | |
| Nucleic Acids | |
| Rats |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24263569 | Interaction between dietary selenium and 2-acetylaminofluorene in the rat. | Biol Trace Elem Res | 1983 | https://conductscience.org/library/papers/24263569 | PubMed |
| 7036954 | Retinol (vitamin A) as a modifier of 2-aminofluorene and 2-acetyl-aminofluorene mutagenesis in the Salmonella/microsome assay. | Arch Toxicol | 1982 | https://conductscience.org/library/papers/7036954 | PubMed |
| 6994684 | Metabolic activation of 2-acetylaminofluorene by isolated rat liver cells. Involvement of different metabolites causing DNA-repair and bacterial mutagenesis. | Arch Toxicol | 1980 | https://conductscience.org/library/papers/6994684 | PubMed |
| 6752940 | Aminofluorene-DNA adduct formation in Salmonella typhimurium exposed to the carcinogen N-hydroxy-2-acetylaminofluorene. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6752940 | PubMed |
| 6400924 | Modulation of genotoxic and cytotoxic effects of aromatic amines in monolayers of rat hepatocytes. | Cell Biol Toxicol | 1984 | https://conductscience.org/library/papers/6400924 | PubMed |
| 6339222 | Genotoxicity of N-acetylarylamines in the salmonella/hepatocyte system. | Environ Health Perspect | 1983 | https://conductscience.org/library/papers/6339222 | PubMed |
| 6131820 | Acetylation, deacetylation and acyltransfer. | Environ Health Perspect | 1983 | https://conductscience.org/library/papers/6131820 | PubMed |
| 2415084 | Effects of vitamin A on the metabolism and mutagenicity of 2AAF in vitro and on the covalent binding to rat liver DNA/RNA in vivo. | Arch Toxicol | 1985 | https://conductscience.org/library/papers/2415084 | PubMed |
| 2253053 | A comparison of the inhibition of deacetylase in primary cultures of rat and human hepatocytes effecting metabolism and DNA-binding of 2-acetylaminofluorene. | Cell Biol Toxicol | 1990 | https://conductscience.org/library/papers/2253053 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/203386
GET https://conductscience.org/api/papers/v1/203386/authors